The Federal Trade Commission (FTC) on Friday sued the three largest pharmacy benefit managers (PBMs) for engaging in alleged ...
Millions of Americans with diabetes need insulin to survive, yet for many of these vulnerable patients, their insulin drug ...
The federal government is suing some pharmacy benefit managers over a system of drug rebates that regulators say has made the ...
The federal government has initiated a lawsuit against leading Pharmacy Benefit Managers (PBMs) — Caremark, Express Scripts, and OptumRx — accusing them of anticompetitive practices that have driven ...
The FTC accuses the largest pharmacy benefit manager companies of unfairly boosting prices on prescription drugs.
Cigna may have the edge with smaller footprint and focused approach, but all three giants face risks from FTC's lawsuit over inflated insulin prices.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback